Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

86.95
Delayed Data
As of Feb 09
 -2.68 / -2.99%
Today’s Change
69.33
Today|||52-Week Range
263.81
-14.46%
Year-to-Date

Today’s Trading

Previous close89.63
Today’s open87.90
Day’s range84.14 - 91.94
Volume6,729,583
Average volume (3 months)13,009,454
Market cap$30.6B
Dividend yield--
Data as of 4:02pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+23.07%
Earnings growth (next 5 years)+15.49%
Revenue growth (last year)+43.22%
P/E ratio36.0
Price/Sales5.93
Price/Book5.64

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-2.69-1.93%
SHPGShire+0.82+0.55%
MYLMylan NV+0.29+0.57%
PRGOPerrigo Company PLC+0.95+0.69%
Data as of 4:02pm ET, 02/09/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)$2.60
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Howard Bradley Schiller
Chief Financial Officer &
Executive Vice President
Robert L. Rosiello
Corporate headquarters
Laval, Quă©bec

Forecasts

Partner Offers